Background: In Uganda, since the confirmation of the first case of Influenza A (H1N1) on July 1, 2009, Influenza-like illnesses (ILI), were reported in school clusters in September. The clusters were investigated to confirm ILI and determine the causative strains.
Methods: Clinical records were reviewed and specimens collected for laboratory testing. Epidemiological analysis of data was done for descriptive and analytical reporting. The WHO ILI case definition was adapted as any person with fever, cough, headache, runny nose, and sore throat in the last 3 to 5 days. A total of 543 specimens of throat and nasal swabs from different clusters and individuals were collected for laboratory testing and epidemiological analysis. Case based surveillance was administered to all students in the first school cluster (Kitabi Seminary), with ILI from beginning of September 2009 to assess the clinical and possible exposure history. Line lists were used to collect demographic and clinical information from the other clusters.
Results: Pandemic influenza A (H1N1) 2009 in was confirmed in 13/18 school clusters. The index case in the first cluster with a sustained H1N1 transmission was a student who came with the infection from the holiday. In the school clusters, the number with ILI symptoms ranged from 50-430. The major signs and symptoms from the first cluster were cough 341/403(84.6%), headache 330/403(81.9%), sneezing 288/403(71.5%), general body weakness 283/403(70.5%), fever 269/403(66.7%), runny nose 208/403(51.6%), sore throat 104/403(25.8%), and others 126/403(31.3%). The attack rate as determined from first cluster by dormitory of residence ranged from 47.1 -89.1 per 100 population, with a mean of 76.2 per 100 population. The nested case control analysis from the laboratory database revealed a significant association with confirmed cases of H1N1 and having fever OR 1.68(CI: 1.16-2.45), and cough OR 1.86(CI: 1.2-2.86).
Conclusion: The H1N1 pandemic in Uganda has since the confirmation of the first case, reached high levels of person to person transmission resulting in clustered epidemics. Observations from the case control analysis reveal a more likelihood of finding an H1N1 positive laboratory result from a patient with fever and cough compared from the other Influenza-like illnesses. Methods: An exploratory analysis was performed to identify factors associated with death among confirmed cases of influenza A/H1N1, considering the residents and other people treated in healthcare facilities in SP, from EW 16 to 41. Data were collected from the Information System of Notifiable Hazards -Influenza Online. Association between remarkable expositions and death caused by influenza A/H1N1 was investigated by unadjusted odds ratio estimation, with 95% confidence intervals, employing the EpiInfo software.
Results: In SP, since EW 16, 31.589 influenza A/H1N1 suspected cases were reported, from which 5.242 (16,6%) were confirmed and fulfilled the criteria for Severe Acute Respiratory Disease. Among these, 372 cases resulted in death, 3.619 were discharged from hospital and 1.251 are still under investigation. The following variables showed association with death caused by influenza A/H1N1: chronic cardiopathy OR = 3,00 (IC95% = 2,05-4,40); chronic renal failure OR = 3,85 (IC95% = 2,02-7,33); immunosuppression OR = 4, 93 (IC95% = 3, 25) ; tobacco abuse OR = 1,52 (IC95% = 1,03-2,26); chronic metabolic disease OR = 6,36 (IC95% = 4,27-9,48); diarrhea OR = 1,56 (IC95% = 1,16-2,10);); residence in the metropolitan area of Greater Sao Paulo in relation to the interior of state OR = 1,37 (IC95% = 1,11-1,70). Variables which did not present association with death were: lack of previous vaccination against influenza OR = 1,65 (IC95% = 0,93-2,93) or pneumococcus OR = 1,22 (IC95% = 0,44-3,39); chronic pneumopathy OR = 1,14 (IC95% = 0,80-1,61); haemoglobinopathy OR = 1,74 (IC95% = 0,60-5,04).
Conclusion: Widespread knowledge of influenza A/H1N1 epidemiology, its complications and risk factors for death is extremely important to support the implementation of strategies to prevent and control this disease in high-risk groups. Comparison of data found in the assessed population with other similar studies is recommended. doi:10.1016/j.ijid.2010.02.1698
